Evidence-based medication use among Chinese patients with acute coronary syndromes at the time of hospital discharge and 1 year after hospitalization: results from the Clinical Pathways for Acute Coronary Sydromes in China (CPACS) study. American Heart Journal. 2009; 157:509-516. .
Gaps in cardiovascular disease risk management in Australian general practice. Medical Journal of Australia. 2009;191:324-9..
How to Treat – Cardiovascular Disease Risk Assessment. Australian Doctor. 2009:25-31..
Impact of glucose control on macrovascular and microvascular disease: insights from ADVANCE. In: American Heart Association Scientific Sessions. American Heart Association Scientific Sessions. Orlando, US; 2009..
Intensive glucose control and macrovascular outcomes in type 2 diabetes. Diabetologia. 2009;52:2288-98.